home / stock / mpsyf / mpsyf message board
Subject | By | Source | When |
---|---|---|---|
Emylers: MPSYF Financials 07/16/2014 03:24:38 MorphoSys AG Period Ending Total Revenue Cost of Reven | Emylers | investorshangout | 07/16/2014 8:24:35 AM |
Stock Tracker: Latest Morphosys Ag (MPSYF) Headlines Novartis Strengthens in Oncology With Multiple | Stock_Tracker | investorshangout | 03/10/2014 8:40:12 PM |
chartguy89: MPSYF 97.21 Stock Charts $MPSYF 1 Month Chart | chartguy89 | investorshangout | 03/08/2014 9:38:56 PM |
chartguy89: MPSYF Stock Charts Last: -0.70 Friday, February 28, 2014 at 2:05:11 AM $MPSYF 1 | chartguy89 | investorshangout | 02/28/2014 7:05:23 AM |
News, Short Squeeze, Breakout and More Instantly...
Morphosys Ag Ord Company Name:
MPSYF Stock Symbol:
OTCMKTS Market:
Additional ASCO 2024 poster presentation will include new findings from the Phase 2 study of tulmimetostat PLANEGG and MUNICH, GERMANY / ACCESSWIRE / April 24, 2024 / MorphoSys AG (FSE:MOR)(NASDAQ:MOR) today announced that new efficacy and safety data from the Phase 3 MANIFEST-2 trial of pel...
Novartis offers € 68.00 per share in cash, representing a total equity value of € 2.7 billion Shareholders benefit from attractive premium of 94% and 142% on the volume-weighted average price during the last month and three months before January 25, 2024, respectively Acce...
PLANEGG and MUNICH, GERMANY / ACCESSWIRE / March 22, 2024 / MorphoSys AG (FSE:MOR)(NASDAQ:MOR) today announced the receipt of U.S. antitrust clearance under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (the "HSR Act") in connection with the proposed acquisition of MorphoSys by Novart...